{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:40:23Z","timestamp":1756384823555,"version":"3.40.4"},"reference-count":16,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2015,12,6]]},"abstract":"<jats:p>Epistaxis is a potentially life-threatening condition that can compromise a patient's airway, breathing and circulation. Early recognition of underlying bleeding diatheses that are amenable to medical therapy is imperative in order for timely treatment and to reduce morbidity. We present a case in which acquired haemophilia was diagnosed in an 83-year-old man presenting with seemingly uncomplicated epistaxis. The patient suffered multisite haemorrhages and haemodynamic compromise before definitive management with monoclonal antibody therapy. The case highlights the difficulties in managing this rare condition. It also emphasises the importance of clotting assay analysis in patients who present with epistaxis in the absence of an underlying anticoagulant.<\/jats:p>","DOI":"10.1136\/bcr-2015-213528","type":"journal-article","created":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T07:07:58Z","timestamp":1451632078000},"page":"bcr2015213528","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["A rare and life-threatening cause of epistaxis"],"prefix":"10.1136","volume":"2015","author":[{"given":"Rory","family":"McDonald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anant Piyush","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudine","family":"Horrocks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,12,23]]},"reference":[{"key":"2025042707564604000_2015.dec23_1.bcr2015213528.1","first-page":"129","article-title":"The frequency of epistaxis in a male population sample","volume":"13","author":"Petruson","year":"1975","journal-title":"Rhinology"},{"key":"2025042707564604000_2015.dec23_1.bcr2015213528.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0807078"},{"key":"2025042707564604000_2015.dec23_1.bcr2015213528.3","first-page":"444","article-title":"Management of epistaxis: a national survey","volume":"78","author":"Kotecha","year":"1996","journal-title":"Ann R Coll Surg Engl"},{"key":"2025042707564604000_2015.dec23_1.bcr2015213528.4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04731.x"},{"key":"2025042707564604000_2015.dec23_1.bcr2015213528.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-029850"},{"key":"2025042707564604000_2015.dec23_1.bcr2015213528.6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0038-1650169","article-title":"A survey of 215 non-hemophiliac patients with inhibitor to Facto VIII","volume":"45","author":"Green","year":"1981","journal-title":"Thromb Haemost"},{"key":"2025042707564604000_2015.dec23_1.bcr2015213528.7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0038-1651666","article-title":"Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment","volume":"73","author":"Hauser","year":"1995","journal-title":"Thromb Haemost"},{"key":"2025042707564604000_2015.dec23_1.bcr2015213528.8","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1055\/s-0038-1665434","article-title":"The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study","volume":"78","author":"Hay","year":"1997","journal-title":"Thromb Haemost"},{"key":"2025042707564604000_2015.dec23_1.bcr2015213528.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06087.x"},{"key":"2025042707564604000_2015.dec23_1.bcr2015213528.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07915.x"},{"key":"2025042707564604000_2015.dec23_1.bcr2015213528.11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2516.2003.00856.x","article-title":"Treatment of acquired haemophilia with factor eight inhibitor bypassing activity","volume":"10","author":"Sallah","year":"2004","journal-title":"Haemophilia"},{"key":"2025042707564604000_2015.dec23_1.bcr2015213528.12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-409185"},{"key":"2025042707564604000_2015.dec23_1.bcr2015213528.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2010.08.005"},{"key":"2025042707564604000_2015.dec23_1.bcr2015213528.14","doi-asserted-by":"publisher","DOI":"10.1177\/1076029608319442"},{"key":"2025042707564604000_2015.dec23_1.bcr2015213528.15","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200302000-00018"},{"key":"2025042707564604000_2015.dec23_1.bcr2015213528.16","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-199206000-00009"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2015-213528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T14:56:54Z","timestamp":1745765814000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2015-213528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,23]]},"references-count":16,"alternative-id":["10.1136\/bcr-2015-213528"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2015-213528","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2015,12,23]]}}}